Collegium Pharmaceutical, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Collegium Pharmaceutical, Inc. (COLL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$478.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$449.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$29.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$341.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$111.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$2.98M.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$362.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$8.00K.
- Collegium Pharmaceutical, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$206.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$478.00K 10-Q · filed 2017-08-09 | -$819.00K derived: sum of 3 quarters · filed 2017-08-09 | -$930.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | -$29.00K 10-Q · filed 2017-05-10 | -$370.00K derived: sum of 2 quarters · filed 2017-05-10 | -$481.00K derived: sum of 3 quarters · filed 2017-05-10 | |
| 2016-12-31 | -$341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$452.00K derived: sum of 2 quarters · filed 2017-03-10 | -$2.98M 10-K · filed 2017-03-10 | |
| 2016-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$2.64M 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | -$2.52M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$339.00K derived: sum of 2 quarters · filed 2017-03-10 | -$362.00K 10-K · filed 2017-03-10 | |
| 2015-09-30 | -$152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$175.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$23.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | -$8.00K 10-K · filed 2017-03-10 | |||
| 2013-12-31 | -$206.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |